e-learning
resources
Virtual 2021
06.09.2021
Respiratory infections
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Late Breaking Abstract - Value of the interleukin profile can be an objective standart for control the tactics of managing patients with bronchiolitis
P. Berezhanskiy (Moscow, Russian Federation), A. Andjel (Moscow, Russian Federation), A. Malachov (Moscow, Russian Federation), V. Elagina (Moscow, Russian Federation)
Source:
Virtual Congress 2021 – Respiratory infections
Session:
Respiratory infections
Session type:
Oral Presentation
Number:
1660
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Berezhanskiy (Moscow, Russian Federation), A. Andjel (Moscow, Russian Federation), A. Malachov (Moscow, Russian Federation), V. Elagina (Moscow, Russian Federation). Late Breaking Abstract - Value of the interleukin profile can be an objective standart for control the tactics of managing patients with bronchiolitis. 1660
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Risk factors of adverse outcome after acute hospitalization in Idiopathic Pulmonary Fibrosis (IPF)
Lane-hamilton syndrome and CCF: a fatal association
Related content which might interest you:
Late Breaking Abstract - Treatment with ATYR1923 reduces biomarkers in COVID-19 pneumonia
Source: Virtual Congress 2021 – Diagnosis and management of COVID-19
Year: 2021
Late Breaking Abstract - Clinical characteristics and lung function trends of severe eosinophilic asthma patients unresponsive to Mepolizumab
Source: International Congress 2019 – Blood eosinophils and more in airway diseases
Year: 2019
Late Breaking Abstract - Use of mepolizumab in bronchiectasis with underlying eosinophilic condition
Source: International Congress 2018 – New methods for diagnosing and treating lung diseases
Year: 2018
Late Breaking Abstract - Defining a severe asthma super-responder: findings from a Delphi process
Source: Virtual Congress 2020 – Advances in asthma treatment
Year: 2020
Late Breaking Abstract - Patients with severe eosinophilic asthma benefit from the treatment with Anti-IL-5 Reslizumab – a real life study from Austria
Source: International Congress 2018 – Notable Studies in Asthma
Year: 2018
Late Breaking Abstract - Evaluating the feasibility, safety, and efficacy of senolytics in idiopathic pulmonary fibrosis
Source: International Congress 2019 – Idiopathic pulmonary fibrosis and surroundings
Year: 2019
Late Breaking Abstract - Early response to benralizumab in Canadians with severe eosinophilic asthma
Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies
Year: 2021
Late Breaking Abstract - Comparative analysis of effectiveness of Asthma Control Test-guided treatment versus usual care in patients with asthma from China
Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases
Year: 2020
Late Breaking Abstract - Determinants of disease control in patients with severe COPD. The CLAVE Study
Source: International Congress 2019 – Clinical approach to asthma management
Year: 2019
Late Breaking Abstract - Promising results of the infliximab biosimilar Inflectra® in severe sarcoidosis patients
Source: International Congress 2017 – The many faces of sarcoidosis
Year: 2017
Late Breaking Abstract - Capnography for ultimately simple diagnostics of COPD
Source: International Congress 2017 – Innovation in COPD: techniques and facts
Year: 2017
Late Breaking Abstract - Use of a simple telecoaching pulmonary rehabilitation protocol for COPD patients.
Source: International Congress 2019 – Breathing, posture and physical activity in respiratory disease patients
Year: 2019
Late Breaking Abstract - Comparative real world effectiveness of triple therapy versus dual bronchodilation in frequently exacerbating patients with COPD
Source: International Congress 2018 – COPD exacerbations and bronchiectasis
Year: 2018
Late Breaking Abstract - Effects of pulmonary rehabilitation on major symptoms of long COVID (post-COVID-19 syndrome): preliminary results
Source: Virtual Congress 2021 – A multidisciplinary approach to pulmonary rehabilitation and management of chronic respiratory diseases
Year: 2021
Late Breaking Abstract - Daily physical activity in patients with severe eosinophilic asthma and the effect of anti-IL5 therapy.
Source: International Congress 2018 – New pharmacological strategies in airway diseases
Year: 2018
Late Breaking Abstract - Corticosteroid optimisation in severe asthma using composite biomarkers to adjust dose versus a symptom/risk-based algorithm
Source: Virtual Congress 2020 – ALERT: Asthma in adults and children
Year: 2020
Late Breaking Abstract - Lung ultrasound for severity assessment and outcome prediction of COVID-19 patients.
Source: Virtual Congress 2020 – Transthoracic and endobronchial ultrasound
Year: 2020
Late Breaking Abstract - Lung function tests in patients with previous SARS-COV2 pneumonia: a useful follow-up tool
Source: Virtual Congress 2021 – Exacerbations of chronic respiratory diseases, including SARS-CoV-2
Year: 2021
Late Breaking Abstract - Overlap of SGRQ and CAT-defined chronic mucus hypersecretion in the SPIROMICS cohort: implications for digital health
Source: International Congress 2018 – COPD exacerbations and bronchiectasis
Year: 2018
Late Breaking Abstract - iPREDICT: Pilot study to develop predictive model of changes in asthma control
Source: International Congress 2019 – Lung function evaluation and prognosis of airway diseases
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept